Garrett Lynch, MD
Sports Medicine · Annapolis, MDNPI 1063477917
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $1,218,707 of the $1,378,440 with a category attached, or 88.4%. Anika Therapeutics, Inc. accounts for 100.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $1,218,787 and has fallen 100.0% since, to $14 in 2023. Among sports medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $114,870 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$1.4M
- Baxter Healthcare$80
- Zimmer Biomet$57
- Boston Scientific$43
What the payments were for
- Food & beverage$1800%
- Ownership interest$1,218,70788%
- Other$159,55312%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 4 | $1,378,260 |
| Baxter Healthcare | 3 | $80 |
| Zimmer Biomet | 2 | $57 |
| Boston Scientific | 3 | $43 |
How this compares
$1,378,440 in reported general payments places this provider in the 95th percentile of 111 sports medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 278 | $2,086 |
| Diclofenac Sodium | 104 | $1,655 |
| Celecoxib | 27 | $554 |
| Nabumetone | 31 | $474 |
| Prednisone | 113 | $346 |
| Ibuprofen | 32 | $282 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Annapolis
- Robert WaltzAnnapolis$43K
- David KeblishAnnapolis$8K
- Evan MichaelsonAnnapolis$8K
- Daniel RedziniakAnnapolis$3K
- Raymond ThalBethesda$779K
- Jason ScoppSalisbury$637K
- John ChristoforettiBethesda$418K
- Jonas RudzkiChevy Chase$386K
- Matthew LevineFrederick$364K
- Abdulaziz AhmedBaltimore$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.